Profil
Thierry Bertrand Lambert currently works at Berkem SA, as Independent Director from 2021.
Mr. Lambert also formerly worked at Naturex SA, as Chief Financial & Administrative Officer from 2014 to 2015, Safe SA (France), as Chief Financial Officer from 2015 to 2017, and Theranexus SA, as Chief Financial & Administrative Officer from 2017 to 2024.
Mr. Lambert received his Masters Business Admin degree from INSEAD and undergraduate degree from the University of Birmingham.
Aktiva positioner av Thierry Bertrand Lambert
| Företag | Position | Start |
|---|---|---|
| GROUPE BERKEM | Direktör/Styrelseledamot | 2021-03-08 |
Tidigare kända positioner av Thierry Bertrand Lambert
| Företag | Position | Slut |
|---|---|---|
| THX PHARMA | Finansdirektör/CFO | 2024-04-01 |
| SAFE S.A. | Finansdirektör/CFO | 2017-11-09 |
| NATUREX | Finansdirektör/CFO | 2015-03-31 |
Thierry Bertrand Lamberts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Naturex SA
Naturex SA Chemicals: SpecialtyProcess Industries Manufactures essential oils | Process Industries |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berkem SA
Berkem SA Chemicals: SpecialtyProcess Industries Operates as a holding company whose subsidiaries engages in construction materials, health beauty nutrition, hygiene protection and industry products | Process Industries |
Safe SA (France)
Safe SA (France) Medical SpecialtiesHealth Technology Manufactures medical implants and single-use medical instruments for spinal surgery | Health Technology |
Theranexus SA
Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases | Health Technology |
















